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Introduction 49
Congenital ureteropelvic junction obstruction (UPJO) is the most common cause of hydronephrosis 50 in the ante-and neonatal period and is detected in approximately 1 % of newborns (25). The 51 obstruction is more common on the left side, usually partial and chronic, unless surgically corrected 52 (19) . Extensive studies on hydronephrosis have been performed using an animal model of UPJO, in 53 which the left ureter is surgically inserted into the underlying psoas muscle to create a partial and 54 chronic obstruction of urinary flow (8). This experimental approach yielded a more discrete 55 obstruction, distinct from the dramatic acute total occlusion model that differs a lot from the clinical 56 scenario with UPJO. Previous studies in both rats and mice have demonstrated a significant link 57 between the degree of UPJO-induced hydronephrosis and the development of hypertension in adult 58 life (8, 10-12). The UPJO-induced hypertension is salt-sensitive, and associated with elevated renin 59 (10) and aldosterone levels (24). UPJO is accompanied by kidney injuries manifested by fibrosis 60 and inflammation on the ipsilateral side as well as proteinuria, while the morphology/histology of 61 the contralateral kidney is basically normal apart from having enlarged glomeruli (24) . 62
Hypertension is attenuated or even cured following relief of the obstruction or, notably, by removal 63 of the hydronephrotic kidney (12). Moreover, recent studies show that ambulatory blood pressure in 64 pediatric patients with congenital hydronephrosis is higher compared with healthy controls, and 65 surgical correction of the obstruction significantly lowers blood pressure (2, 3). Thus, preclinical 66 and clinical findings indicate that the UPJO kidney contributes to the development of hypertension, 67 which is of salt-sensitive nature. Since data from rodents suggested increased activity of the RAAS 68 (8, 11, 24), it was hypothesized in the present study that RAAS is reversibly elevated in human 69 pediatric patients with congenital hydronephrosis due to UPJO. The renal mechanism underlying 70 salt-sensitivity of blood pressure is not clear. If elevated RAAS is relevant in pediatric patients, it 71 would predict up-regulation of aldosterone-sensitive Na transport proteins in the distal nephron and 72 collecting ducts, in particular the apical thiazide sensitive Na-Cl co-transporter (NCC), the 73 epithelial Na channel (ENaC) and the basolateral Na-K-ATPase. Moreover, the significant 74 proteinuria in the obstructed kidney could be accompanied by aberrant filtration of plasma proteases 75 into urine, to proteolytically activate ENaC and drive salt-sensitive hypertension (30) (31) (32) (33) 35) . Thus, 76
ENaC could with unchanged protein abundance be inappropriately activated by proteolysis in the 77 obstructed kidneys. The present study was undertaken to examine the hypotheses that i) in pediatric 78 patients with UPJO the RAAS is activated prior to surgical relief of the obstruction; ii) in rats with 79 UPJO the RAAS activation is reflected by increased abundance of renal aldosterone-stimulated Na 80 transporters and sensitivity of blood pressure to a RAAS antagonist; and iii) the injured UPJO 81 kidney allows aberrant filtration of plasminogen leading to proteolytic activation of γ-ENaC. 82 5
Methods 83
Ethics 84
Animal study: The experimental study was approved by the institutional ethics review board in 85
Stockholm (N139/15 & N314/12). All animal procedures were performed according to the 86 guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals 87 used for scientific purposes or National Institutes of Health guidelines. 88
Clinical study: The clinical study was approved by the regional ethical review board in Uppsala, 89
Sweden (EPN; Protocol Number 2011/ 267). Every child's guardian gave informed consent. The 90 study adhered to the principles of the Declaration of Helsinki. For details regarding the study 91 population (Research design and Methods) please see previously published study (2). 92 93
Collection of human plasma and urine samples 94
Plasma and urine samples from twelve patients with unilateral congenital hydronephrosis were 95 analyzed. Matched plasma samples from before (UPJO+) and after surgical treatment (UPJO-) were 96 available and analyzed from eight patients (2), while matched urine samples from ten patients 97 (before and after surgery) were available and analyzed. Only children with hydronephrosis that was 98 not associated with any other diseases and did not receive antihypertensive medication were 99 included in the study. Material from eight healthy age-and sex-matched controls were included 100 (Ctrl). The inclusion was achieved at the Pediatric Surgery Department of Uppsala University 101
Children's Hospital in Uppsala, Sweden. Ambulatory blood pressure was measured for 20-24 hours 102 preoperatively and repeated six months postoperatively in the hydronephrosis group (2). Similarly, 103 20-24 hours ambulatory blood pressure was measured in the control group. All urine, blood and kidney tissue samples were from male Sprague-Dawley rats (Scanbur Charles 108 River), either sham-operated or with UPJO to induce hydronephrosis, from published series (24). 109 UPJO was created in three week old rats as previously described (9, 11, 24) . In brief, the abdomen 110 was opened by a midline incision and the left ureter was isolated and dissected free. The underlying 111 psoas muscle was carefully split and the ureter was positioned inside the muscle and ligated to 112 create a partial obstruction, and the abdomen was closed again, as originally described by Carlstrom 113 et al. (11) . Sham operation was performed in the same way, without dissecting the ureter. Following 114 surgery, all animals were left to grow with free access to standard rodent chow (normal salt diet; 115 0.7% NaCl) and tap water. A telemetry device (PA-C40, DSI™, St Paul, MN, USA) was implanted 116 in 8 weeks old rats to assess cardiovascular function, as described previously (9, 11, 24). After an 117 acclimatization period of 10 days, blood pressure was continuously recorded in unrestrained 118 animals for 48 hours. At termination, blood was collected from the abdominal vena cava and 119 centrifuged, and plasma was frozen for later analysis. Excised kidneys were cleaned and the 120 hydronephrotic ratio was calculated as previously described (i.e., residual renal urine weight / renal 121 parenchymal weight) (11). An intervention series was conducted to examine the influence of the 122 RAAS on blood pressure after experimental UPJO. Similar to that described above; UPJO was 123 induced and a telemetry device was implanted. After the acclimatization period, blood pressure was 124 continuously recorded during baseline (4 days) followed by treatment with an angiotensin-125 converting enzyme (ACE) inhibitor (captopril, 1 mg/ml) for 8 days. Darmstadt, Germany), 150 mM NaCl (Sigma-Aldrich, Copenhagen, Denmark), 20mM NaF 132 (Sigma-Aldrich), 10mM Na4P2O7 (Sigma-Aldrich), 1% Triton X-100 (Sigma-Aldrich) and 1 tablet 133 cOmplete™ tablet protease inhibitor per 50 mL (Roche Diagnostics, Sigma-Aldrich)) with an 134 electric homogenizer, before placed on ice for 30 minutes at 4 °C. The samples were centrifuged at 135 12,000 rpm at 4 °C and the supernatant were collected and frozen at -80 °C before further analysis. 136
The specificity of the NCC antibody was tested in rat homogenate, which was separated by 137 centrifugation into: mainly plasma-bound proteins (pellet after 17,000 g), mainly subcellular 138 vesicles (pellet after 200,000 g) and non-membrane bound proteins (supernatant after 200,000 g). 139
Protein concentration was determined using DC protein assay (Bio-Rad, Copenhagen, Denmark). 140
Urinary and plasma measurements 141
Albumin in urine was determined using a pre-coated albumin ELISA kits for human (108788, 142 Abcam, Cambridge, UK) and rat (KSP-198, Nordic Biosite, Täby, Sweden) respectively. In the rats 143 total urinary protein excretion rates were quantified using DC TM protein assay (Biorad), while 144 human urinary Na and K were measured by a routine clinical procedure by department of Clinical 145
Biochemistry at Odense University Hospital. 146
Urinary creatinine measurements in human samples were available from previous experiments 147
(2). Aldosterone concentration in plasma and urine was determined with Aldosterone ELISA (MS 148 E-5200, LDN, Labor Diagnostika Nord, Germany). Human EDTA-plasma was used as an internal 149 standard, 79 ± 8 pg/ml. Between-assay coefficient of variation is 10%. Between-assay coefficient of variation was 15%. Angiotensin II (AngII) hormone concentrations in 159 plasma were measured by radioimmunoassay (using specific antibodies and charcoal-plasma to 160 separate bound antigen from free) after extraction performed by use of Sep-Pak C18 columns 161 (Waters, Millipore Corporation, Milford, MA, USA). Immunoreactivity of AngII in plasma extracts 162 was measured using antibody Ab-5-030682 raised in rabbits. The antibody was used as described 163 previously (6). Essentially, plasma was incubated with antibody (final dilution of 1:1 000 000) and Kidneys from rat were homogenized and pelleted as described in detail previously(14) with minor 173 modifications. Kidneys were homogenized in fractionation buffer (140 mM NaCl, 10 mM Tris-174
Base, 1 mM EDTA, 0.5 mM EGTA) and spun for 2,000 g for 10 min. The supernatant was spun 175 down at 17.000g for 30 min and saved. The resulting supernatant was then centrifuged at 200.000g 176 for 30 min. Both pellet and supernatant was saved for western blotting. due to lack of normal distribution also after log transformation). Plasma AngII concentration was 242 below detection range in four cases (one from the control group, one from pre-operated group and 243 two from the post operated group). These were not included in the analysis. No significant 244 difference was detected between the groups (Fig. 2C ) or before and after surgery ( fig.2D ). There 245 was no significant difference in plasma and urine aldosterone concentrations between the groups 246 ( fig. 2E , G) and no difference before and after surgical intervention in the obstruction group ( fig.  247 2F, H). Soluble pro-renin receptor (sPRR) was determined in urine. Nine samples, three from each 248 group, were below detection range and were not included. No difference was detected between the 249 groups ( fig. 2I ) or before and after surgical intervention ( fig. 2J ). No correlation was found between 250 24-hours mean arterial blood pressure measurements in the hydronephrotic group and plasma-251 aldosterone, urinary-aldosterone, plasma-AngII, plasma-renin or urinary-PRR respectively (table 1) 252 or between the Δ values of the blood pressure before and after surgery and the Δ values of the 253 RAAS hormones (table 1). No difference was detected in urinary Na/K ratio (not shown). In agreement with previous studies (11, 24), UPJO was associated with increased MAP in 267 comparison to sham-operated animals (108 ± 2 vs. 90 ± 2, p <0.0001, Fig.4A ). UPJO resulted in 268 increased 24h urinary excretion of total protein-and albumin compared to sham-group (Fig. 4B, C) . 269
There was no association between MAP and urinary protein-and albumin excretion (table 2). The 270 degree of hydronephrosis (HNR) correlated directly with MAP in UPJO rats (table 2) (11). 271
Hydronephrosis was not detected in the sham-operated rats (HNR <0.05). A positive correlation 272 was found between plasma aldosterone levels (24) and MAP (24) in the UPJO group ( fig.4D , table  273 13 2). There was a significant (p=0.003) blood pressure reduction in response to ACE inhibition in rats 274 with hydronephrosis ( fig.4E ). Although not statistically significant (p=0.05), the averaged reduction 275 in blood pressure during the treatment period clearly trended (p=0.05) to be more pronounced in 276 UPJO rats (delta -11 mmHg) compared with that observed in sham rats (delta -6 mmHg) ( fig.4F ). 277
No relation was observed between MAP and plasma renin or AngII concentration (table 2) . 278
Likewise, in the sham-operated rats, no correlation was detected between MAP and plasma-279 aldosterone, renin or AngII respectively (data not shown). 
Effect of UPJO on Na transport proteins in rat kidney 293
The abundance of aldosterone-regulated Na transport proteins in kidney tissue was determined by 294 western blot in ipsi-and contralateral kidneys from UPJO rats and in kidneys from sham operated 295 rats. A newly developed murine monoclonal anti-NCC antibody yielded a product with the 296 expected molecular size at ≈150 kDa in rat kidney that was pre-absorbed by pre-incubation with 297 surplus of immunizing peptide ( fig.6A ). Immunoblotting for total NCC in UPJO and control rats 298 
Effect of UPJO on γ-ENaC abundance in rat kidney tissue 317
Western blotting on kidney tissue with antibody against the C-terminus of γ-ENaC revealed three 318 well-defined bands in rat homogenates at ≈80-90 kDa, ≈37 and 20 kDa ( fig.8A ). As loading-and 319 housekeeping control, β-actin protein showed no difference in abundance between or within groups 320
and was used to normalize all γ-ENaC densitometry values. No difference in abundance between 321 UPJO+, UPJO-and control was detected in the ≈80-90 kDa band ( fig. 8B,C) . The 37kDa band 322 appeared with higher density in UPJO-compared to their obstructed counterpart, UPJO+ ( fig.8D,  323 p=0.047). A significant lower density in mean was detected in the ≈37kDa band in UPJO+ kidneys 324 compared to sham (p < 0.004), while no significant difference was detected between UPJO-and 325 sham or between the UPJO+ and UPJO- (fig. 8E ). The ≈20 kDa showed significant up-regulation in hydronephrosis, cases showed that nephrectomy or pyeloplasty turned patients normotensive (1, 13, 355 29, 37). Furthermore recent studies from our group showed blood pressure is elevated in pediatric 356 patients with hydronephrosis compared with healthy, age-and sex-matched children, and their 357 blood pressure was significantly reduced following surgical management of UPJO (2, 3) . 358
359
The present study showed a significant correlation between degree of hydronephrosis and blood 360 pressure, which is in accordance with the affected kidney as the culprit. The UPJO rat model 361 created various degrees of hydronephrosis corresponding to the clinical setting. The variable degree 362 of hydronephrosis likely accounts for the variation in proteinuria, albuminuria and plasminuria as 363 well as the magnitude of blood pressure elevation. One has to take into consideration that urine 364 collected and analyzed in the present study originates from both kidneys, likely with a lower 365 glomerular filtration rate (GFR) at the affected side, while only the injured kidney contributes to the 366 above mentioned urine sequelae. 367
368
ENaC importantly contributes to the regulation of Na excretion by kidneys. Plasmin(ogen) enters 369 the pre-urine in conditions where the glomerular filtration barrier is damaged and proteolytically 370 cleaves γ-ENaC, resulting in increased ENaC-mediated Na reabsorption (31-33, 38) and 371 development of hypertension in the clinical setting (5, 7) (4). Pediatric patients with UPJO children 372 showed elevated urinary plasmin(ogen) before surgery compared to controls, and UPJO rats had a 373 higher plasmin/plasminogen ratio, indicating that plasmin may play a role in the pathogenesis of 374 hypertension associated with hydronephrosis. 375 376 Kidney tissue from the UPJO rat provided an exceptional opportunity to study the molecular 377 mechanisms in the ipsilateral obstructed kidney in a paired intra-individual design with comparison 378 to the non-obstructed contralateral kidney. Cleaved γ-ENaC in UPJO rat kidney was investigated 379 using an antibody directed against the C-terminal part of γ-ENaC (36). Based on previous studies 380 using the same or similar antibodies (15, 21, 23) it was estimated that the band detected at ≈ 80-90 381 kDa was compatible with intact γ-ENaC, while unexpectedly no furin/plasmin-cleaved γ-ENaC was 382 detected. The ≈ 37 and ≈ 20 kDa bands presumably represent additional, not specified, cleavage 383 products with no known physiological role. Differential changes in abundance of these moieties 384 were observed, however, at this point there is no evidence of physiological relevance of these lower 385 molecular weight bands. Taken together, differences in γ-ENaC cleavage were detected between the 386 groups, although the exact characteristics and physiological relevance of the cleavage products were 387 not clarified and the intact γ-ENaC was unchanged. An explanation could be that proteases in the 388 proteinuric UPJO+ rat is degrading the 37kDa band further and producing the 20kDa band. 389
390
A previous study found, that most of the major Na transporters such as the Na-K-ATPase (27) 391 NHE1 (22), NHE3 (28) and NCC (28) were down regulated in the obstructed kidney in rats with 392 both neonatally-induced UPJO and complete unilateral ureteral obstruction (UUO). Consistent with 393 these previous findings, decreased NCC expression was detected in the UPJO kidney in the present 394 study, while no significant difference was observed for Na/K-ATPase. Moreover, a previous study 395 demonstrated increased urinary water excretion 1 year after neonatally-induced UPJO (18) and a 396 down-regulation of the water channels aquaporin AQP1, AQP2 (27) and AQP3 (17). However, in 397 the present study no significant differences in AQP2 protein expression were detected in the 398 collecting duct. These discrepancies could be explained by the much shorter duration of UPJO in 399 the present study. 400
401
The RAAS has been reported to be slightly elevated in rodent models of UPJO (8, 11, 24) . In 402 agreement, the blood pressure in the UPJO rats correlated significantly with their aldosterone levels 403
and was significantly reduced by ACE inhibition. Aldosterone (24), but not plasma-renin (24), 404 plasma-AngII (24) or pro-renin receptor (present study) was elevated in the UPJO rats. Aldosterone 405 exert its main effects in the distal nephron, with ENaC as its main target under physiological 406 conditions (20, 23). However, the present observations showed no up-regulation of aldosterone-407 sensitive transporters in UPJO. A study from 2006 found that ACE-inhibitor prevented the 408 reduction in renal blood flow and prevented progression of hydronephrosis in UPJO rats, suggesting 409 important contribution of the RAAS (34). However, in that study the authors did not make any albumin, protein, hydronpehrosis ratio (HNR), plasmin/plasminogen ratio and RAAS components 616 in rats with ureteropelvic junction obstruction (UPJO). *=p<0.05. i : Data obtained from previous 617 study(24). 618 
Figure caption

